Bioburden Control in Continuous Bioprocessing

Описание к видео Bioburden Control in Continuous Bioprocessing

An overview of the working principle behind helium integrity testing (HIT™) technology, demonstrating how it can help reduce the risk of potential loss of integrity of single-use systems and to ensure patient safety, drug manufacturers perform risk assessments and develop strategies for the control and assurance of integrity of SUS in partnership with their suppliers.

Learn more about the Pall Helium Integrity Test for Allegro™ Single-Use Systems at https://shop.pall.com/us/en/biotech/f...

Комментарии

Информация по комментариям в разработке